EHRA 2023: Late-Breaking Science Video Collection
Published: 18 April 2023
-
Views:
2041
-
Likes:
7
-
Views:
2041
-
Likes:
7
-
Up Next -
4m 26sPart 1 | Session 2 AdaptResponse: AdaptivCRT® Algorithm in Synchronized LV Pacing -
6m 49sPart 1 | Session 3 MANIFEST-PF: Real-world Experience of PFA in Commercial Practice -
6m 26s -
2m 38sPart 1 | Session 5 TEMPO-HCM: Extended ECG Monitoring in HCM -
3m 37sPart 1 | Session 6 Conformable PVI Catheter for Pulmonary Vein Isolation -
3m 54sPart 1 | Session 7 BRUGADA Randomized: Epidcardial Ablation to Prevent Sudden Death
-
6m 25sPart 2 | Session 1 5 Trials That Will Change Your Practice With Dr Sohaib -
6m 24sPart 2 | Session 2 4 Trials That Will Change Your Practice With Dr Di Biase
-
54sPart 3 | Session 1 Dr Bergonti: Pulsed-Field Ablation & Reasons to Research -
1m 52sPart 3 | Session 2 Dr Bruce Wilkoff: Therapy Morbidity and Advice to Young Researchers -
31sPart 3 | Session 3 Dr Carlo Pappone: Advice to Early-Career Electrophysiologists -
28sPart 3 | Session 4 Dr Juan Caro Codon: Building a Team For Success -
1m 33s
Overview
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.
More from this programme
Part 1
Expert Interviews
Part 2
Featured Highlights
In these concise overviews, selected faculty provide their thoughts on the most impactful trials from EHRA 2023.
Part 3
Behind the Heart
Watch our Behind the Heart series to learn more about the personal perspectives of the investigators behind top trials in cardiovascular science.
About the episode
EHRA 23 - In this short interview, Prof Roland Tilz (University Heart Centre Lübeck, DE) outlines the findings from the POTTER registry.
The POTTER Registry (NCT05273645) gathered data on patients undergoing pulmonary vein isolation (PVI) with a rare complication, atrio-oesophageal fistula (AOF). The registry focuses on the incidence, diagnosis and management of this complication, which affects around 0.016-0.07% of PVI patients. Prof Tilz outlines the patient population, key findings and future prospects of this worldwide, multicenter, retrospective registry.
Questions:
1. What was the rationale behind the creation of this registry?
2. What was the patient population and registry design?
3. What were the key findings?
4. How should these findings inform and shape practice?
Recorded on-site at EHRA 2023, Barcelona.
Editor: Jordan Rance
Faculty Biographies
Roland R Tilz
Prof Roland Tilz is the deputy director of the Medical Center II of the University Hospital in Lübeck and professor of the invasive electrophysiology at the University Lübeck. He is committed to training in the field of “Invasive electrophysiology and cardiac rhythm implants”. Prof Roland Tilz trained at the Addenbrooks Hospital in Cambridge (UK), Bedford Hospital (UK), Klinikum Bayreuth and at the Asklepios Klinik St. Georg in Hamburg.
Comments